E ENCELADUSBIO Trademark

Trademark Overview


On Tuesday, May 9, 2023, a trademark application was filed for E ENCELADUSBIO with the United States Patent and Trademark Office. The USPTO has given the E ENCELADUSBIO trademark a serial number of 97926976. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Enceladus Bio, Inc.. The E ENCELADUSBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases

Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

General Information


Serial Number97926976
Word MarkE ENCELADUSBIO
Filing DateTuesday, May 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "E ENCELADUSBIO" with a design of a sphere forming the letter "E" to the left of the wording "ENCELADUSBIO.".
Goods and ServicesPharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases
Pseudo MarkE ENCELADUS BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnceladus Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York City, NY 10019

Party NameEnceladus Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events


Event DateEvent Description
Friday, May 12, 2023NEW APPLICATION ENTERED
Thursday, June 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 9, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 4, 2023ASSIGNED TO EXAMINER
Monday, September 4, 2023NON-FINAL ACTION WRITTEN
Monday, September 4, 2023NON-FINAL ACTION E-MAILED
Monday, September 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2023SUSPENSION LETTER WRITTEN
Tuesday, December 5, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, December 5, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 20, 2024SOU TEAS EXTENSION RECEIVED